|Bid||1.1600 x 1100|
|Ask||1.1900 x 1100|
|Day's Range||1.1500 - 1.1900|
|52 Week Range||0.9200 - 1.7400|
|Beta (3Y Monthly)||0.98|
|PE Ratio (TTM)||N/A|
|Earnings Date||Nov 5, 2019 - Nov 11, 2019|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||1.69|
Genesis Healthcare (GEN) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Genesis Healthcare (GEN) delivered earnings and revenue surprises of 61.54% and -0.26%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
KENNETT SQUARE, Pa., Aug. 08, 2019 -- Genesis Healthcare, Inc. (Genesis, or the Company) (NYSE:GEN), one of the largest post-acute care providers in the United States, today.
Genesis Healthcare's (GEN) Q2 earnings should benefit from a stable census and reimbursement environment, effective cost management, improvement in therapy and staffing businesses.
Genesis Healthcare (GEN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
KENNETT SQUARE, Pa., July 22, 2019 -- Genesis HealthCare (NYSE:GEN) (Genesis or the Company), one of the nation’s largest providers of post-acute care, today announced that it.
Zacks.com featured highlights include: Guess, Party City, Shoe Carnival, Genesis and Restoration Robotics
KENNETT SQUARE, Pa., July 08, 2019 -- Genesis HealthCare, one of the largest post-acute care providers in the United States, today announced that three of its affiliated.